Kardiologie

Dr. med. Markus Roos

Leitender Arzt Elektrophysiologie Kardiologie
Facharzt für Kardiologie

Fax 052 266 35 15
Klinische Ausbildung
Seit 01/2017Leitender Arzt Rhythmologie Kantonsspital Winterthur
Kardiologie / Departement Medizin
(Chefarzt: Prof. Dr. med. A. Linka)
05/2013–12/2016Interventionelle Elektrophysiologie, seit 01.03.2014 als Oberarzt Herz- und Gefäss-Klinik GmbH Bad
Neustadt a/S, Deutschland
Fachbereich Kardiologie (Chefarzt: Prof. Dr. med T. Deneke)
03/2012–04/2013Assistenzarzt interventionelle Kardiologie Zentralklinik Bad Berka GmbH, Deutschland Klinik für Kardiologie, Abteilung invasive Kardiologie (Chefarzt: Prof. Dr. med. B. Lauer)
03/2012–04/2013Assistenzarzt interventionelle Kardiologie Zentralklinik Bad Berka GmbH, Deutschland Klinik für Kardiologie, Abteilung invasive Kardiologie (Chefarzt: Prof. Dr. med. B. Lauer)
12/2010–02/2012Assistenzarzt invasive Elektrophysiologie Zentralklinik Bad Berka GmbH, Deutschland Klinik für Kardiologie, Abteilung Rhythmologie und invasive Elektrophysiologie
(Chefarzt: Prof. Dr. med. J.C. Geller)
2009–2010Oberarzt Kardiologie (nicht invasive und invasive Tätigkeit)
Herzzentrum, Luzerner Kantonsspital
(Chefarzt: Prof. Dr. med. P. Erne)
2007–2009Fellow in Clinical Electrophysiology
HEART RHYTHM MANAGEMENT CENTRE
Vrije Universiteit Brussel, Belgium
(Head: Prof. Dr. med. P. Brugada)
2005–2007Assistenz- und Oberarzt Kardiologie
Kantonsspital Luzern
(Chefarzt: Prof. Dr. med. P. Erne)
2004Oberarzt Innere Medizin
Kantonsspital Aarau
(Direktor und Chefarzt: Prof. Dr. med. D. Conen)
2001–2003Assistenzarzt Innere Medizin
Stadtspital Triemli, Zürich
(Direktor und Chefarzt: Prof. Dr. med. O. Oelz)
1999–2001Assistenzarzt Innere Medizin
Kantonsspital Olten
(Direktor und Chefarzt: Prof. Dr. med. M. Pirovino)
1998–1999Assistenzarzt Chirurgie
Kantonsspital Baden
(Direktor und Chefarzt: Prof. Dr. med. Säuberli)
1987–1990Software und Hardware Entwicklung
Mettler-Toledo AG, Greifensee
Ausbildung und Diplome
12/2010Deutsche Approbation
01/2010Facharzt Kardiologie, Swiss Medical Association (FMH)
07/2004Facharzt Innere Medizin, Swiss Medical Association (FMH)
04/2003Advanced Cardiovascular Life Support (AHA)
09/2001Clinical Observer in Cardiology, Royal Brompton, London (Prof. Richard Sutton)
1998Doktorat: Dialysat-seitige, effective Clearance während Hämodialysebehandlung: Praktische Erfahrungen. (Prof. Dr. med. U. Binswanger)
1990 – 1997Medizinstudium und Arztdiplom, Universität Zürich, Schweiz
1984 – 1990Studium und Diplom als Elektroingenieur (Dipl. El. Ing ETH), Eidgenössische Technische Hochschule, Zürich, Schweiz

Publikationen in Zeitschriften mit wissenschaftlichen Beirat

  1. M Roos MSc, MD, P Halbfass MD, K Nentwich MD, E Ene MD, A Schade MD, J Bogoviku MD, K Sonne, MD, P Müller MD, F Fochler MD, T Deneke MD, PhD, FHRS;
    Single centre experience in a large cohort of patients undergoing epicardial ventricular tachycardia ablation. Submitted to Circ Arrhythm Electrophysiol.
  2. M Roos, JC Geller and M-A Ohlow.;
    Critical analysis of ineffective post implantation implantable cardioverter-defibrillator-testing. Accepted for publication in World Journal of Cardiology
    2016 Nov
  3. Halbfass P, Müller P, Nentwich K, Krug J, Roos M, Hamm K, Barth S, Szöllösi A, Mügge A, Schieffer B, Deneke T.;
    Incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation using an oesophageal temperature probe with insulated thermocouples: a comparative controlled study. Europace.
    2016 Aug 18.
  4. Ohlow MA, Roos M, Lauer B, Von Korn H, Geller JC.;
    Incidence, predictors, and outcome of inadvertent malposition of transvenous pacing or defibrillation lead in the left heart. Europace.
    2016 Jul;18(7):1049-54.
  5. Halbfass P, Nentwich K, Krug J, Roos M, Sonne K, Ene E, Hamm K, Barth S, Szöllösi A, Fochler F, Mügge A, Lüsebrink U, Deneke T.; Impact of surround flow catheter tip irrigation in contact force ablation on the incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation: a prospective comparative study.
    Europace. 2016 Jun 27.
  6. Müller P, Halbfass P, Szöllösi A, Dietrich JW, Fochler F, Nentwich K, Roos M, Krug J, Schmitt R, Mügge A, Deneke T.;
    Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation. J Interv Card Electrophysiol.
    2016 Sep;46(3):203-11.
  7. Schade A, Nentwich K, Costello-Boerrigter LC, Halbfass P, Mueller P, Roos M, Barth S, Krug J, Szoelloesi GA, Lapp H, Deneke T.; Spatial Relationship of Focal Impulses, Rotors and Low Voltage Zones in Patients With Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol. 2016 May;27(5):507-14.
  8. Ohlow MA, Roos M, Lauer B, Geller JC.;
    Incidence of ineffective safety margin testing (<10 J) and efficacy of routine subcutaneous array insertion during implantable cardioverter defibrillator implantation.: Indian Pacing Electrophysiol J.
    2016 Mar-Apr;16(2):47-52.
  9. Deneke T, Müller P, Halbfaß P, Szöllösi A, Roos M, Krug J, Fochler F, Schade A, Schmitt R, Christopoulos G, Mügge A, Nentwich K.; Effect of different ablation settings on acute complications using the novel irrigated multipolar radiofrequency ablation catheter (nMARQ).
    J Cardiovasc Electrophysiol. 2015 Jun 15.
  10. Müller P, Maier J, Dietrich JW, Barth S, Griese DP, Schiedat F, Szöllösi A, Halbfass P, Nentwich K, Roos M, Krug J, Schade A, Schmitt R, Mügge A, Deneke T.;
    Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.
    J Interv Card Electrophysiol. 2015 Jun 6.
  11. Müller P, Dietrich JW, Halbfass P, Abouarab A, Fochler F, Szöllösi A, Nentwich K, Roos M, Krug J, Schade A, Mügge A, Deneke T.; Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes. Heart Rhythm.
    2015 Jul;12(7):1464-9. doi: 10.1016/j.hrthm.2015.04.005. Epub 2015 Apr 3.
  12. Deneke T, Jais P, Scaglione M, Schmitt R, DI Biase L, Christopoulos G, Schade A, Mügge A, Bansmann M, Nentwich K, Müller P, Krug J, Roos M, Halbfass P, Natale A, Gaita F, Haines D.;
    Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol.
    2015 Apr;26(4):455-63.
  13. Schade A, Schumacher B, Dietrich JW, Langbein A, Groschup G, Koucky K, Krug J, Stahl C, Müller P, Nentwich K, Roos M, Deneke T.; Stand-alone mapping using different transluminal mapping catheters-an accurate and safe way to isolate all pulmonary veins with the cryoballoon? J Interv Card Electrophysiol.
    2015 Jan;42(1):33-41.
  14. Brunelli M, Raffa S, Große A, Hanazawa K, Sammut M, Roos M, Frommhold M, Wauters K, Geller JC.
    Residual conduction after pulmonary vein isolation with a circular multielectrode radiofrequency ablation catheter: The role of adenosine and orciprenalin during a prolonged observation time. Int J Cardiol.
    2013 Oct 9;168(4):4122-31. doi: 10.1016/j.ijcard.2013.07.071. Epub 2013 Aug 4.
  15. Roos M, Sarkozy A, Brodbeck J, Henkens S, Chierchia GB, De Asmundis C, Capulzini L, Müller-Burri SA, Yakazi Y, Brugada P.
    The Importance of Class I Antiarrhythmic Drug Test in the Evaluation of Patients with Syncope: Unmasking Brugada Syndrome. J Cardiovasc Electrophysiol.
    2012 Mar;23(3):290-5. Epub 2011 Oct 10.
  16. Roos M, Brodbeck J, Sarkozy A, Chierchia GB, De Asmundis C, Brugada P.
    A critical analysis of the scientific evidence behind international guidelines related to cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2011 Apr 1;4(2) :202-10. Epub 2011 Mar 3.
  17. Zuber M, Roos M, Kobza R, Toggweiler S, Meier R, Erne P.
    Detection and  hemodynamic significance of cardiac pacemaker-induced phrenic nerve stimulation. Congest Heart Fail.
    2010 Jul ;16(4):147-52
  18. Collins SP, Kontos MC, Michaels AD, Zuber M, Kipfer P, Attenhofer Jost C, Roos M, Jamshidi P, Erne P, Lindsell CJ.
    Utility of a bedside acoustic cardiographic model to predict elevated left ventricular filling pressure. Emerg Med J. 2010
    Sep;27(9):677-82. doi: 10.1136/emj.2009.080150. Epub 2010 Jun 1.
  19. Capulzini L, Paparella G, Sorgente A, de Asmundis C, Chierchia GB, Sarkozy A,
    Muller-Burri A, Yazaki Y, Roos M, Brugada P. Feasibility, safety, and outcome of a challenging transseptal puncture facilitated by radiofrequency energy delivery: a prospective single-centre study.
    Europace. 2010 Feb 23.
  20. Sarkozy A, Chierchia GB, Paparella G, Boussy T, De Asmundis C, Roos M, Henkens S, Kaufman L, Buyl R, Brugada R, Brugada J, Brugada P.;
    Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol.
    2009 Apr;2(2):154-61. Epub 2009 Feb 13.
  21. Roos M, Brugada P.;
    [What is your diagnosis? AV nodal reentry tachycardia]. Praxis (Bern 1994).
    2009 Aug 12;98(16):873-4. German.
  22. Capulzini L, Sarkozy A, Semeraro O, Paparella G, Chierchia GB, DE Asmundis C, Roos M, Yazaki Y, Muller-Burri A, Sorgente A, Brugada P.;
    Ivabradine to Treat Inappropriate Sinus Tachycardia after the Fast Pathway Ablation in a Patient with Severe Pectus Excavatum.
    Pacing Clin Electrophysiol. 2009 Oct 10.
  23. de Asmundis C, Chierchia GB, Sarkozy A, Capulzini L, Paparella G, Müller-Burri SA, Roos M, Yazaki Y, Brugada P.;
    Transseptal puncture for atrial fibrillation ablation in a patient with previous Tirone David intervention: the role of real-time 3D transesophageal echocardiography guidance. J Cardiovasc Med (Hagerstown).
    2009 Jul;10(7):563-4.
  24. de Asmundis C, Chierchia GB, Sarkozy A, Paparella G, Roos M, Capulzini L, Burri SA, Yazaki Y, Brugada P.;
    Novel trans-septal approach using a Safe Sept J-shaped guidewire in difficult left atrial access during atrial fibrillation
    ablation.

    Europace. 2009 May;11(5):657-9. Epub 2009 Apr 10.
  25. Kobza R, Roos M, Niggli B, Abächerli R, Lupi GA, Frey F, Schmid JJ, Erne P.;
    Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts.
    Heart Rhythm. 2009 May;6(5):652-7. Epub 2009 Jan 16.
  26. Vanhoutte K, de Asmundis C, Francesconi A, Figys1 J, Steurs G, Boussy T, Roos M, Mueller A, Massimo L, Paparella G, Van Caelenberg K, Chierchia GB, Sarkozy A, Y Terradellas PB, Zizi M.;
    Leaving out control groups: an internal contrast analysis of gene expression profiles in atrial fibrillation patients – A systems
    biology approach to clinical categorization.

    Bioinformation. 2009;3(6):275-278.
  27. Roos M, Sarkozy A, Chierchia GB, De Wilde P, Schmedding E, Brugada P.;
    Malignant ventricular arrhythmia in a case of adult onset of spinal muscular atrophy (Kugelberg-Welander disease). J Cardiovasc Electrophysiol. 2009
    Mar;20(3):342-4. Epub 2008 Oct 13.
  28. Roos M, Kobza R, Jamshidi P, Bauer P, Resink T, Schlaepfer R, Stulz P, Zuber M, Erne P.;
    Improved cardiac performance through pacing-induced diaphragmatic stimulation: a novel electrophysiological approach in heart failure management?
    Europace. 2009 Feb;11(2):191-9.
  29. Chierchia GB, de Asmundis C, Müller-Burri SA, Sarkozy A, Capulzini L, Paparella G, Chierchia S, Roos M, Brugada P.;
    Early recovery of pulmonary vein conduction after cryoballoon ablation for paroxysmal atrial fibrillation: a prospective study.
    Europace. 2009 Apr;11(4):445-9. Epub 2008 Dec 22.
  30. Chierchia GB, Capulzini L, de Asmundis C, Sarkozy A, Roos M, Paparella G, Boussy T, Van Camp G, Kerkhove D, Brugada P.;
    First experience with real-time three-dimensional transoesophageal echocardiography-guided transseptal in patients undergoing atrial fibrillation ablation.
    Europace. 2008 Nov;10(11):1325-8. Epub 2008 Oct 3.
  31. Kobza R, Roos M, Toggweiler S, Zuber M, Erne P.;
    Recorded heart sounds for identification of ventricular tachycardia. Resuscitation.
    2008 Nov;79(2):265-72. Epub 2008 Jul 24.
  32. Roos M, Toggweiler S, Jamshidi P, Zuber M, Kobza R, Meier R, Erne P.;
    Noninvasive detection of left ventricular systolic dysfunction by acoustic cardiography in cardiac failure patients.
    J Card Fail. 2008 May;14(4):310-9.
  33. Cuculi F, Walz B, Zuber M, Roos M, Erne P.;
    Clinical correlates of very high brain natriuretic peptide levels in hospitalized patients.
    Am Heart Hosp J. 2008 Winter;6(1):37-41.
  34. Zuber M, Toggweiler S, Roos M, Kobza R, Jamshidi P, Erne P.;
    Comparison of different approaches for optimization of atrioventricular and interventricular delay in biventricular pacing.
    Europace. 2008 Mar;10(3):367-73. Epub 2008 Jan 29.
  35. Toggweiler S, Zuber M, Kobza R, Roos M, Jamshidi P, Meier R, Erne P.;
    Improved response to cardiac resynchronization therapy through optimization of atrioventricular and interventricular delays using acoustic cardiography: a pilot study.
    J Card Fail. 2007 Oct;13(8):637-42.
  36. Toggweiler S, Kobza R, Roos M, Erne P.;
    Visualizing pacemaker-induced phrenic nerve stimulation with acoustic cardiography.
    Pacing Clin Electrophysiol. 2007 Jun;30(6):806-7.
  37. Roos M, Kobza R, Erne P.;
    Early pacemaker battery depletion caused by a current leak in the output circuitry: rectification not exchange. Pacing Clin Electrophysiol.
    2007 May;30(5):705-8.
  38. Frick S, Roos M, Fattinger K.;
    How much is too much? Oligosymptomatic presentation after 11.5 g of diphenhydramine.
    Hum Exp Toxicol. 2007 Feb;26(2):131-3.
  39. Roos M, Toggweiler S, Zuber M, Jamshidi P, Erne P.;
    Acoustic cardiographic parameters and their relationship to invasive hemodynamic measurements in patients with left ventricular systolic dysfunction. Congest Heart Fail. 2006
    Jul-Aug;12 Suppl 1:19-24.